Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alembic Pharmaceuticals Ltd market cap is 201.34B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alembic Pharmaceuticals Ltd 52 week high is 1,094.00 as of May 04, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alembic Pharmaceuticals Ltd 52 week low is 542.40 as of May 04, 2024.
Alembic Pharmaceuticals Ltd stock price today is 1,024.65.
Alembic Pharmaceuticals Ltd stock price yesterday was 999.95.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alembic Pharmaceuticals Ltd’s P/E ratio is 34.11.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alembic Pharmaceuticals Ltd P/B ratio is 4.5042.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Alembic Pharmaceuticals Ltd's EBITDA is 18.21.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alembic Pharmaceuticals Ltd 50-day moving average is 989.07.
Alembic Pharmaceuticals Ltd has 16,640 employees.